Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Medspoke's Talks
Medspoke
Medspoke
Clinical Cancer Research
Published October 21, 2026
DuoBody®-FAPαxDR4 is a novel DR4 agonist that induces potent antitumor activity through FAPα-depe...
October 23, 2026
Medspoke
Medspoke
Clinical Cancer Research
Published October 21, 2026
00:00
--:--
Serial circulating tumour DNA monitoring in first-line advanced NSCLC (COPE): a randomized, two-a...
October 23, 2026
Share
Serial circulating tumour DNA monitoring in first-line advanced NSCLC (COPE): a randomized, two-arm non-comparative phase II trial.
https://www.medspoke.co/channel_journal?id=686&tap_id=16126
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Medspoke
Medspoke
Clinical Cancer Research
Published October 21, 2026
Carboplatin Plus Mirvetuximab Soravtansine In Platinum-Sensitive Ovarian Cancer: A Phase 2 Nonran...
October 23, 2026
Why are you reporting this TALK?
